Management Team

Gamma Therapeutics executive management team and consultants is comprised of experienced life science business executives and scientists with broad and in depth experience in hemostasis, thrombosis and coagulation research; pathology and diagnostic testing; military medicine and combat casualty care; trauma surgery and medicine; FDA regulatory process; product development, marketing and launch; life science venture management; business development; strategic partnering; channel sales relationships, and; international distribution.


David Farrell, PhD, Founder & Chief Scientific Officer:
33-year researcher in the areas of hemostasis, thrombosis and coagulation, 18 years as a Principal Investigator; Professor of Surgery, Department of Surgical Medicine, Oregon Health & Science University; Director, Health Sciences Technology Entrepreneurship Certificate Program; Fellow, American Heart Association; B.S. in Biochemistry, UCLA, Ph.D. in Biological Sciences, University of California, Irvine; Former Asst. Professor Biochemistry & Molecular Biology, Penn State College of Medicine; and, former Chair, SBIR grants study section, National Institutes of Health.

David F. Eastman, MS, Chief Executive Officer:

35-year experienced Life Science industry executive developing products and launching start-up ventures in medical systems, software, biotechnology and medical devices.  Formerly CEO of Yecuris Corporation, a venture start-up developing humanized mouse models for drug discovery; executive product marketing manager at Becton Dickinson, Fresenius Corporation and Cordis Dow Medical; consultant for 26 medical device start-ups; Co-Chair, OHSU Start-Up Advisory Group; BOD, OmnEcoil, MagnetoOrganics & NeuraMedica; B.S. in Marketing and Communications, University of Northern Colorado; M.S., Business, Marketing and Design, University of Oregon; Executive MBA Medical Product Marketing Certificate Program, UCLA Anderson School of Management.

Copyright © 2010, Gamma Therapeutics, Inc. All rights reserved.